Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units

Virology

Volumn 311, Issue 1, 2003, Pages 89-95

  Kugler S ^a   Lingor, P ^a   Scholl U ^a   Zolotukhin, S ^b   Bahr M ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; SYNAPSIN I; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CELL; CELL CULTURE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; RETINA NERVE CELL; THALAMUS NUCLEUS; TRANSCRIPTION REGULATION; TRANSGENE;

ADENO-ASSOCIATED VIRUS 2; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; MOUSE CYTOMEGALOVIRUS 1; MURINAE;

EID: 17144444172     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00162-4     Document Type: Article

References (20)

1. Addison C.L., Hitt M., Kunsken D., Graham F.L. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors. J. Gen. Virol. 78:1997;1653-1661.
2. Bähr M. Live or let die - retinal ganglion cell death and survival during development and in the lesioned adult CNS. Trends Neurosci. 23:2000;483-490.
3. Bartlett J.S., Samulski R.J., McCown T.J. Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum. Gene Ther. 9:1998;1181-1186.
4. Björklund A., Kirik D., Rosenblad C., Georgievska B., Lundberg C., Mandel R.J. Towards a neuroprotective gene therapy for Parkinson's disease use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model . Brain Res. 886:2000;82-98.
5. de Hoop, M.J., Meyn, L., Dotti, C.G., 1998. Culturing hippocampal neurons and astrocytes from fetal rodent brain, in: Cell Biology: A Laboratory Handbook, Academic Press, San Diego, CA, pp. 154-164.
6. Dong J.Y., Fan P.D., Frizzell R.A. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum. Gene Ther. 7:1996;2101-2112.
7. Gerdes C.A., Castro M.G., Lowenstein P.R. Strong promoters are the key to highly efficient, noninflammatory and noncytotoxic adenoviral-mediated transgene delivery into the brain in vivo. Mol. Ther. 2:2000;330-338.
8. Glover C.P., Bienemann A.S., Heywood D.J., Cosgrave A.S., Uney J.B. Adenoviral-mediated, high-level, cell-specific transgene expression a SYN1-WPRE cassette mediates increased transgene expression with no loss of neuron specificity . Mol. Ther. 5:2002;509-516.
9. Grimm D., Kern A., Rittner K., Kleinschmidt J.A. Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum. Gene Ther. 9:1998;2745-2760.
10. Kermer P., Klöcker N., Weishaupt J.H., Bähr M. Transection of the optic nerve in rats studying neuronal death and survival in vivo . Brain Res. Brain Res. Protoc. 7:2001;255-260.
11. Kügler, S., Kilic, E., Bähr, M., 2002. Human synapsin 1 gene promoter confers neuron-specific long-term transgene expression from adenoviral vectors in the adult rat brain depending on the transduced area. Gene Ther. 10, 337-347.
12. Kügler S., Klöcker N., Kermer P., Isenmann S., Bähr M. Transduction of axotomized retinal ganglion cells by adenoviral vector administration at the optic nerve stump an in vivo model system for the inhibition of neuronal apoptotic cell death . Gene Ther. 6:1999;1759-1767.
13. Kügler S., Meyn L., Holzmüller H., Gerhardt E., Isenmann S., Schulz J.B., Bähr M. Neuron-specific expression of therapeutic proteins evaluation of different cellular promoters in recombinant adenoviral vectors . Mol. Cell Neurosci. 17:2001;78-96.
14. Paterna J.C., Moccetti T., Mura A., Feldon J., Bueler H. Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain. Gene Ther. 7:2000;1304-1311.
15. Paxinos G., Watson C. The Rat Brain in Stereotaxic Co-ordinates. 1998;Academic Press, San Diego, CA.
16. Peel A.L., Klein R.L. Adeno-associated virus vectors activity and applications in the CNS . J. Neurosci. Methods. 98:2000;95-104.
17. Rabinowitz J.E., Rolling F., Li C., Conrath H., Xiao W., Xiao X., Samulski R.J. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol. 76:2002;791-801.
18. Sandford G.R., Burns W.H. Rat cytomegalovirus has a unique immediate early gene enhancer. Virology. 222:1996;310-317.
19. Zolotukhin S., Byrne B.J., Mason E., Zolotukhin E., Potter M., Chesnut K., Summerford C., Samulski R.J., Muzyczka N. Recombinant adeno-associated virus purification using novel methods improved infectous titer and yield. Gene Ther. 6:1999;973-985.
20. Xu R., Janson C.G., Mastakov M., Lawlor P., Young D., Mouravlev A., Fitzsimons H., Choi K.L., Ma H., Dragunow M., Leone P., Chen Q., Dicker B., During M.J. Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Ther. 8:2001;1323-1332.